Key Takeaways
- Gold prices fell nearly 2% to approximately $4,075 per ounce as U.S. military strikes on Iranian targets triggered an oil price surge, stoking fears of persistent inflation and higher-for-longer interest rates.
- President Donald Trump announced that U.S. drug prices have shifted from the world's highest to the lowest, citing a 400%-600% price differential following aggressive negotiations and the expansion of the TrumpRx.gov platform.
- Knowledge Atlas Technology (02513), also known as Zhipu AI, launched a massive share placement to raise HK$31.4 billion ($4 billion), pricing 19.78 million new H shares at HK$1,588 each.
- South Korea's financial regulators are on high alert as chip stocks and leveraged ETFs now command over 70% of total market trading volume, creating extreme volatility in the KOSPI.
- UK housing sentiment remains fragile with the RICS House Price Balance hitting -33% in June, slightly better than the previous month but still reflecting a market under significant pressure.
Geopolitical Escalation Rattles Commodity Markets
Gold's traditional status as a safe-haven asset was overshadowed by inflationary concerns today as U.S. military strikes against more than 80 Iranian targets sent energy prices soaring. Brent crude jumped over 5% toward $76 per barrel, leading investors to bet that the Federal Reserve will maintain a hawkish stance to combat energy-driven inflation. The inverse relationship between rising yields and non-yielding bullion saw spot gold slide below the $4,100 mark, reaching its lowest level in nearly a week.
Trump Claims "Historic" Reduction in Prescription Costs
In a prime-time address, President Donald Trump declared a total reversal in American pharmaceutical costs, claiming the U.S. has moved from paying the highest drug prices globally to the lowest. Trump highlighted a 400%-600% difference in pricing achieved through "Most-Favored-Nation" agreements and direct negotiations with major pharmaceutical firms. The administration also announced an expansion of TrumpRx.gov, which now features over 600 generic medications and direct-to-consumer cash pricing models.
AI Giant Knowledge Atlas Seeks $4 Billion in Hong Kong
Chinese AI leader Knowledge Atlas Technology (02513) is capitalizing on a 1,500% stock surge since its January listing by issuing 19.78 million new H shares. The offering, priced at HK$1,588 per share, represents a discount of approximately 13% to the most recent closing price. Net proceeds of HK$31.37 billion are earmarked for R&D, including the development of custom AI chips and the expansion of its GLM-5.2 large language model.
South Korean "Ants" Drive Record Market Volatility
Retail investors in South Korea, known as "ants," have pushed the market into a state of extreme concentration, with Samsung Electronics (005930) and SK Hynix (000660) related products now dominating 70% of market activity. The Financial Supervisory Service (FSS) expressed deep concern over the proliferation of single-stock leveraged ETFs, which have amplified price swings and triggered multiple circuit breakers. Analysts warn that this "casino-like" environment is weighing on broader investor sentiment despite the long-term growth narrative of the AI sector.
UK Housing Market Shows Tepid Signs of Stabilization
The Royal Institution of Chartered Surveyors (RICS) reported a June house price balance of -33%, a marginal improvement from May's -35% reading. While the figure was slightly worse than the -30% forecast, the data suggests the pace of the UK's housing market decline may be finding a floor. However, buyer demand and agreed sales remain firmly in negative territory, as high mortgage rates and macroeconomic uncertainty continue to deter prospective homeowners.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.